GURU.Markets stock price, segment price, and overall market index valuation
The company's share price MGRM
Monogram is a company developing robotic systems for orthopedic surgery. Its stock price represents a venture bet on its technology. The chart reflects high volatility and relies on FDA approval and commercialization success.
Share prices of companies in the market segment - Medical instruments
Monogram Technologies develops next-generation robotic surgical systems for orthopedic procedures such as joint replacements. We've categorized it under "Medical Instruments." The chart below shows how investors view the future of robotic surgery.
Broad Market Index - GURU.Markets
Monogram Technologies develops next-generation robotic surgical systems for orthopedic procedures such as joint replacements. We've categorized it under "Medical Instruments." The chart below shows how investors view the future of robotic surgery.
Change in the price of a company, segment, and market as a whole per day
MGRM - Daily change in the company's share price MGRM
The daily price change of Monogram, a developer of surgical robots, reflects the volatility of the medical technology sector. change_co measures the reaction to news about technological breakthroughs and regulatory approvals. This metric is important for analyzing innovative medical companies on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Medical instruments
Monogram Technologies Inc. is a medical technology company. This chart shows high volatility. Comparison with MGRM's performance, with its robotic surgical system, helps to assess it as a high-risk asset.
Daily change in the price of a broad market stock, index - GURU.Markets
Monogram is a manufacturer of robotic surgical systems. The medical technology market is growing rapidly, but it is also highly competitive. The chart below shows the volatility in this sector, helping to assess how Monogram shares are responding to innovation.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization MGRM
Monogram Technologies' year-over-year performance is a story of robotic surgery's advancement in orthopedics. Its 12-month market cap reflects progress toward FDA approval for its robotic knee surgery system, which promises greater precision and personalization than existing methods.
Annual dynamics of market capitalization of the market segment - Medical instruments
Monogram Technologies develops robotic systems for orthopedic surgery. Its technology is designed to improve the precision of implantation. Its stock price is extremely volatile, reflecting investors' faith in its breakthrough potential and ability to compete with the giants of the robotic surgery market.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Monogram, which develops surgical robots, is a highly speculative stock. Its performance since its IPO is unrelated to economic cycles, but rather depends on its ability to secure regulatory approval and compete with the giants. Its chart is a tale of hope and disappointment, typical of medical tech startups.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization MGRM
As a medical robotics company, Monogram's value will be speculative. Monthly fluctuations on the chart will reflect not revenue, but rather news about development progress and approvals for its robotic system for orthopedic surgery.
Monthly dynamics of market capitalization of the market segment - Medical instruments
Monogram Technologies is developing a next-generation robotic surgical system for high-precision joint replacement surgeries. The graph below shows the overall dynamics in the medical instrument sector, where robotics is a key trend.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Monogram Technologies develops robotic systems for orthopedic surgery. It is a high-tech medical device company in the commercialization stage. Its stock price is driven by news of regulatory approvals and initial sales, rather than by overall market trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization MGRM
Shares of Monogram Technologies, which develops robotic systems for orthopedic surgery, reflect expectations in the MedTech sector. Weekly price action is highly volatile and depends on news about technological progress and the path to commercialization. The chart below shows how short-term events affect the valuation of this medical startup.
Weekly dynamics of market capitalization of the market segment - Medical instruments
How unique is Monogram Technologies' performance in the MedTech sector? This chart compares the orthopedic robotics developer's weekly stock price movements with the industry average. The analysis will reveal whether its movements are driven by unique news about its technology, as is typical for startups, or whether it follows general sentiment.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Monogram Technologies develops robotic systems for orthopedic surgery. This chart compares its weekly performance to the market. It helps understand what's driving the stock: the general trend in medical technology or news about the implementation of its innovative systems in leading clinics, which is key to its growth.
Market capitalization of the company, segment and market as a whole
MGRM - Market capitalization of the company MGRM
The price chart of Monogram Technologies is a bet on its robotic system for orthopedic surgery. The company's market cap, which is on track for commercialization, reflects hopes that its technology will make joint replacement surgeries more precise. The dynamics illustrate the risks and potential of this new medical device.
MGRM - Share of the company's market capitalization MGRM within the market segment - Medical instruments
Monogram Technologies is seeking market share by developing a next-generation robotic system for orthopedic surgery. Its market cap reflects the potential of its personalized approach to joint replacement surgery.
Market capitalization of the market segment - Medical instruments
This chart shows the total market capitalization of developers of robotic systems for orthopedics. Monogram Technologies is seeking to carve out a niche in this market. The dynamics in the chart reflect how the market values innovations that can make joint replacement surgeries more precise and personalized.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart depicts the market valuation of the future of robotic joint surgery. Monogram Technologies' market capitalization reflects investors' faith in its unique system for personalized implantation. The line shows how orthopedic innovations are attempting to gain market share in the global medical equipment industry.
Book value capitalization of the company, segment and market as a whole
MGRM - Book value capitalization of the company MGRM
This chart illustrates the technological foundation of Monogram Technologies. Its assets include patents and prototypes of a robotic surgical system for joint implantation. The graph's dynamics show how the company is investing in the development and commercialization of its innovative medical robotics.
MGRM - Share of the company's book capitalization MGRM within the market segment - Medical instruments
Monogram Technologies' tangible assets aren't massive factories, but rather R&D centers and equipment for developing its next-generation robotic surgical system. The chart shows its share of this high-tech medical infrastructure, which aims to personalize orthopedic surgeries.
Market segment balance sheet capitalization - Medical instruments
Below you can see the overall book value of the medical equipment sector. Against this backdrop, Monogram, with its robotic system for joint surgery, is capital-intensive. Creating surgical robots is a business that requires massive investments in R&D and precision engineering.
Book value of all companies included in the broad market index - GURU.Markets
Monogram Technologies is developing a robotic system for orthopedic surgery. The company's assets are not mass production, but prototypes, patents, and a team of engineers. The company's balance sheet is an investment in the creation of a "robot surgeon," which promises to improve the precision and outcomes of real-life surgeries.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - MGRM
Monogram's balance sheet is made up of its cash and surgical robot prototypes. Its market capitalization is a bet on its technology being able to compete with market giants. The MvsBCap_Co chart shows how much the "dream" of a new surgical robot is worth compared to the company's actual assets.
Market to book capitalization ratio in a market segment - Medical instruments
Monogram Technologies develops robotic systems for orthopedic surgery. Its value lies in its technology, which promises to make joint replacement surgeries more precise. The chart demonstrates the market's high appreciation for its innovations and potential to transform surgical practice.
Market to book capitalization ratio for the market as a whole
Monogram Technologies develops a robotic system for orthopedic surgery, specifically joint replacements. The company's value lies in its technology, which is designed to improve surgical precision. This chart helps explain why the medical technology and robotics sector often trades at a premium to its book value.
Debts of the company, segment and market as a whole
MGRM - Company debts MGRM
For Monogram Technologies, a company developing robotic systems for orthopedic surgery, debt is a tool for bringing a product to market. This chart shows how the company raises capital to complete development, obtain FDA approval, and commercialize it. In the medical device industry, debt is the bridge between the prototype and the operating room.
Market segment debts - Medical instruments
Monogram Technologies is developing a robotic system for orthopedic surgery, specifically joint replacements. Implementing robotics in medicine requires significant investment in R&D and regulatory approvals. This chart shows how the company is funding the development and commercialization of its high-tech surgical platform.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio MGRM
Monogram Technologies develops robotic systems for orthopedic surgery. This chart shows how much the company relies on debt to bring its complex technology to market. In the medical robotics sector, debt is an investment in the future, but also a significant risk associated with the lengthy approval and clinical implementation process.
Market segment debt to market segment book capitalization - Medical instruments
Monogram Technologies develops robotic systems for orthopedic surgery, specifically for joint implantation. This is a high-tech niche in medicine. The chart shows how the company's debt load, dedicated to R&D, compares to the overall market capitalization of the medical device sector.
Debt to book value of all companies in the market
Monogram Technologies (MGRM) is developing a next-generation robotic system for orthopedic surgery. Medical technologies require significant investment in R&D and certification. This chart shows the overall market debt load, demonstrating why companies like Monogram typically have minimal debt at the market entry stage.
P/E of the company, segment and market as a whole
P/E - MGRM
This chart shows the valuation of Monogram Technologies, a company developing robotic systems for orthopedic surgery. P/E ratio is not relevant here. The company's valuation is a bet on its technology's potential to improve the precision of joint replacement surgeries. Its performance depends on progress in securing approvals and initial commercial successes.
P/E of the market segment - Medical instruments
This chart illustrates the average P/E for medical device manufacturers. For Monogram, with its robotic system, it serves as a backdrop. It shows how highly investors value already profitable companies, providing context for Monogram's valuation, which is betting on the future adoption of its innovative surgical technology.
P/E of the market as a whole
Monogram Technologies is developing a next-generation robotic surgical system for orthopedic surgeries such as joint replacements. The company aims to improve the precision and personalization of procedures using 3D printing and robotics. This risk appetite chart helps understand how investors are evaluating new technologies in medical robotics.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company MGRM
Monogram Technologies is developing a next-generation robotic system for orthopedic surgery, specifically joint replacements. This graph shows expectations for the future of robotic surgery. This estimate is speculative and depends on FDA approval, successful product launch, and competition with existing systems.
%20P%2FE%20MGRM&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-MGRM&v=1772581135831 "Chart of the company's future (projected) P/E MGRM")
Future (projected) P/E of the market segment - Medical instruments
Monogram Technologies is developing a robotic system for orthopedic surgery, specifically joint replacements. This chart compares the company's future profitability expectations with those for the medical equipment sector. It reflects the market's belief that their technology can improve surgical precision and compete with market leaders.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Medical-instruments&v=1772581135880 "Future (projected) P/E graph of the market segment - Medical instruments")
Future (projected) P/E of the market as a whole
Monogram Technologies develops robotic systems for orthopedic surgery. Its goal is to improve the precision of implant placement. The company's success depends on the commercialization of its technology. This market expectations chart demonstrates investor willingness to invest in innovative medical devices with long development cycles.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772581135894 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit MGRM
Monogram Technologies is developing a next-generation robotic system for orthopedic surgery, specifically joint replacements. The goal is to increase precision and improve patient outcomes. Financial indicators reflect the costs of developing and obtaining regulatory approvals for this complex medical technology.
Profit of companies in the market segment - Medical instruments
Monogram Technologies is developing a robotic system for orthopedic surgery, aiming to improve the precision of implant placement. The company is on track for commercialization. This chart for the medical device sector illustrates how robotics and AI are transforming surgery, where initial investment in development can lead to significant profitability in the future.
Overall market profit
Monogram Technologies develops robotic systems for orthopedic surgery. The company's goal is to improve the precision of implant placement. Its growth depends on the introduction of new technologies into the conservative medical field. This is a story of innovation whose dynamics are unrelated to the general economic trends that shape this graph.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company MGRM
Monogram Technologies is developing a robotic system for orthopedic surgery, specifically joint replacements. This chart shows revenue expectations, which depend on regulatory approval and successful commercialization of its robot. Surgeon acceptance of the new technology will determine future revenue.
%20profit%20of%20the%20company%20MGRM&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-MGRM&v=1772581135960 "Graph of future (projected) profit of the company MGRM")
Future (predicted) profit of companies in the market segment - Medical instruments
Monogram Technologies is developing a robotic system for orthopedic surgery, specifically for joint implantation. This chart shows the revenue forecast for the medical instruments sector. It reflects expectations for the implementation of robotics in surgery to improve surgical precision. This trend is the main driver of the potential success of Monogram's technology.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Medical-instruments&v=1772581136005 "Graph of future (predicted) profits of companies in a market segment - Medical instruments")
Future (predicted) profit of the market as a whole
Monogram Technologies is developing a robotic system for orthopedic surgery. As a company in the technology implementation stage, it depends on investment and the willingness of hospitals to purchase its expensive equipment. Economic growth, as projected in the graph, makes it easier for hospitals to access capital to invest in innovative medical technologies.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772581136022 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - MGRM
Monogram Technologies is developing a next-generation robotic system for joint replacement surgeries. Its goal is to improve the precision and personalization of implants. This chart shows how investors value its technology, which could transform the orthopedic surgery market, focusing on future sales rather than current revenue.
P/S market segment - Medical instruments
Monogram Technologies is developing a next-generation robotic surgical system for joint replacement surgeries. The company aims to improve the precision and personalization of implants using 3D printing and machine vision. This chart shows the average market value for the sector, helping to understand the market premium placed on Monogram's potentially disruptive technology.
P/S of the market as a whole
Monogram Technologies is developing a robotic system for orthopedic surgery that uses 3D printing and machine vision to create personalized implants and precisely place them. This chart compares the medical technology company's lofty revenue estimates with the more mundane figures of traditional companies.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company MGRM
Monogram Technologies develops robotic systems for orthopedic surgery. Being in the early stages, the company is valued based on its future potential. This chart shows how investors value its technology and prospects in the medical robotics market, factoring in future system sales.
%20P%2FS%20MGRM&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-MGRM&v=1772581136120 "The graph of the company's future (projected) P/S MGRM")
Future (projected) P/S of the market segment - Medical instruments
Monogram Technologies is developing a next-generation robotic system for joint replacement surgeries. This chart compares the company's estimated future sales with those of other medical instrument manufacturers. It reflects investor expectations for its technology, which promises to improve the precision and personalization of orthopedic surgery.
%20P%2FS%20market%20segment%20graph%20-%20Medical%20instruments&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Medical-instruments&v=1772581136165 "Future (projected) P/S market segment graph - Medical instruments")
Future (projected) P/S of the market as a whole
Monogram Technologies is developing a robotic system for orthopedic surgery. This is high-tech medicine. The optimism reflected in this graph affects hospital budgets. During periods of economic growth, they are more inclined to invest in expensive, innovative equipment that can improve surgical outcomes.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772581136175 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales MGRM
Monogram Technologies is developing a next-generation robotic system for high-precision joint replacement surgeries. While in the development and regulatory approval phase, the company has no commercial revenue yet. The schedule will reflect a lack of sales until its technology is commercially available.
Sales of companies in the market segment - Medical instruments
Monogram Technologies is developing a next-generation robotic surgical system for joint replacement surgeries. The company's system uses 3D printing and machine vision to create custom implants and precisely position them. This chart illustrates the growing robotic surgery market, where Monogram is seeking to carve out a niche with its innovative approach.
Overall market sales
Monogram Technologies develops robotic systems for orthopedic surgery. The implementation of such expensive and complex systems depends on hospital capital budgets. This situation, reflecting overall economic health, affects the financial ability of medical institutions to invest in advanced surgical technologies.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company MGRM
Monogram Technologies is developing a robotic system for orthopedic surgery, specifically joint replacements. The company's goal is to improve the precision of implant placement. This graph reflects analysts' expectations regarding the adoption of robotic technologies in surgery and Monogram's ability to compete with existing systems.
%20sales%20of%20the%20company%20MGRM&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-MGRM&v=1772581136325 "Schedule of future (projected) sales of the company MGRM")
Future (projected) sales of companies in the market segment - Medical instruments
Monogram Technologies is developing a robotic system for orthopedic surgery using 3D printing and machine vision. This chart illustrates expectations for the medical instrument sector. It helps assess whether the company's cutting-edge technology can offer surgeons greater precision in implant placement and challenge established players.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Medical-instruments&v=1772581136456 "Schedule of future (projected) sales of companies in the market segment - Medical instruments")
Future (projected) sales of the market as a whole
Monogram Technologies develops robotic systems for orthopedic surgery. This chart, reflecting hospital investments in medical technology, is important to the company. Economic growth allows clinics to purchase advanced equipment to improve surgical precision and patient outcomes, which is Monogram's target market.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772581136505 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality MGRM
Monogram Technologies is developing a next-generation robotic system for orthopedic surgery, specifically joint replacement. The company's business operates at the intersection of medicine and robotics. This chart reflects the current R&D and regulatory expenditures required to bring this cutting-edge surgical technology to market.
Market segment marginality - Medical instruments
Monogram Technologies is developing a robotic system for orthopedic surgery, specifically joint replacements. Their goal is to improve precision and personalize implants. This chart reflects their investment in developing this sophisticated surgical technology, which has the potential to significantly improve patient outcomes and deliver high cost-effectiveness.
Market marginality as a whole
Monogram Technologies is developing a next-generation robotic system for orthopedic surgery, specifically joint replacement. Overall profitability is less important to them. Their business is focused on improving surgical precision and outcomes. Profitability will depend on FDA approval and convincing surgeons of the superiority of their robot.
Employees in the company, segment and market as a whole
Number of employees in the company MGRM
Monogram Technologies is developing a robotic system for orthopedic surgery using 3D printing and artificial intelligence. This graph shows the team of engineers and surgeons. The growth of the team is a direct indicator of progress in the development and preparation for commercialization of this high-tech system.
Share of the company's employees MGRM within the market segment - Medical instruments
Monogram Technologies is developing a next-generation robotic system for orthopedic surgery, specifically joint replacement. This chart shows its market share in the niche field of medical robotics. It reflects the team of engineers and surgeons working to create more precise and personalized solutions for patients requiring implants.
Number of employees in the market segment - Medical instruments
Monogram Technologies is developing a robotic system for orthopedic surgery, specifically for the high-precision placement of knee implants. This chart shows the growth of employment in the medical technology sector. The increase in engineers reflects efforts to commercialize innovative technology that can improve the outcomes of orthopedic surgeries.
Number of employees in the market as a whole
Monogram Technologies is developing a robotic system for orthopedic surgery that enables the creation of personalized implants with high precision. This is the future of orthopedics. This graph shows overall employment, and the MedTech sector, represented by Monogram, is one of the most innovative, creating jobs for robotics engineers, programmers, and surgeons.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company MGRM (MGRM)
Monogram Technologies Inc. develops robotic solutions for orthopedic surgery. It's a high-tech medical business, where value is determined by unique technology and patents. This chart shows a very high market capitalization per employee. The market appreciates the potential of their robotic system to make surgeries more precise and efficient.
%20of%20the%20company%20MGRM%20(MGRM)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-MGRM-MGRM&v=1772581137158 "Chart of market capitalization per employee (in thousands of dollars) of the company MGRM (MGRM)")
Market capitalization per employee (in thousands of dollars) in the market segment - Medical instruments
Neuberger Berman is a large private investment management firm. Its key asset is the talent and reputation of its portfolio managers. This chart allows you to assess how effectively the company utilizes its intellectual capital to attract assets and generate value, comparing it to other Wall Street giants.
%20by%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Medical-instruments&v=1772581137257 "Market capitalization per employee (in thousands of dollars) by market segment - Medical instruments")
Market capitalization per employee (in thousands of dollars) for the overall market
Monogram Technologies is developing a robotic system for orthopedic surgery, specifically for the placement of joint implants. The company's value lies in its technology, which aims to improve surgical precision. This chart reflects investors' confidence in the potential of their robotic platform to improve surgical outcomes.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772581137377 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company MGRM (MGRM)
Monogram Technologies (MGRM) is developing a robotic system for orthopedic surgery (implant placement). This is medtech R&D. This graph shows the "cost" of developing this complex robotics—the negative profit (expense) for each engineer working on the system.
%20Chart%20MGRM%20(MGRM)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-MGRM-MGRM&v=1772581137444 "Company Profit Per Employee (in thousands of dollars) Chart MGRM (MGRM)")
Profit per employee (in thousands of dollars) in the market segment - Medical instruments
Monogram Technologies develops next-generation robotic surgical systems for orthopedic surgeries (joint replacements). Their business is R&D. This chart shows an industry benchmark. It helps evaluate how effectively the Monogram team is using investor capital to build their ambitious robotics platform.
%20in%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Medical-instruments&v=1772581137476 "Chart of profit per employee (in thousands of dollars) in the market segment - Medical instruments")
Profit per employee (in thousands of dollars) for the market as a whole
Monogram Technologies (MGRM) is developing a next-generation robotic system for orthopedic surgery (joint replacement). This complex robotics and R&D project requires sophisticated robotics and is currently in the pre-commercial stage. This chart shows the investment required per engineer and employee to develop and validate this complex medical system.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772581137519 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee MGRM (MGRM)
Monogram Technologies develops robotic systems for orthopedic surgery. This chart reflects the development and commercialization stage. Low or zero revenue per employee is typical for companies whose complex medical technology has not yet received all regulatory approvals and is not yet widely available.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-MGRM-MGRM&v=1772581137546 "Sales chart per company employee MGRM (MGRM)")
Sales per employee in the market segment - Medical instruments
Monogram Technologies (MGRM) is developing a next-generation robotic system (mBôs) for joint replacement surgery (knee, hip). This graph shows the minimal revenue generated by each employee (engineer). It reflects the R&D stage and progress in commercializing their robotics in medical technology.
Sales per employee for the market as a whole
Monogram Technologies (MGRM) is a robotics company developing robots for orthopedic surgery (joint replacement). They aim to improve surgical precision using AI. They are an R&D company in the commercialization stage. This graph (near zero) shows the very beginning of their journey: how their engineering team is trying to turn the technology into sales of robotic systems to surgeons.
Short shares by company, segment and market as a whole
Shares shorted by company MGRM (MGRM)
Monogram Technologies is a company developing a robotic system for orthopedic surgery (joint replacement). This chart shows bearish bets. The shorts are due to the company attempting to enter a market dominated by giants (Stryker, Zimmer), and its technology has not yet received widespread approval or proven its superiority.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-MGRM-MGRM&v=1772581137630 "Short Shares Chart for the Company MGRM (MGRM)")
Shares shorted by market segment - Medical instruments
Monogram Technologies (MGRM) is a company at the intersection of robotics and orthopedics, developing a robot for high-precision placement of joint implants. This chart shows the odds against the MedTech sector. The rising odds against the industry reflect investor skepticism about MGRM's ability to compete with giants like Stryker and Zimmer and gain FDA approval.
Shares shorted by the overall market
Monogram Technologies (MGRM) is developing next-generation robotic systems for orthopedic surgery. It's a high-tech medical startup. This market fear chart shows when investors are unwilling to fund R&D. For MGRM, which is unprofitable, this panic means difficulties raising capital.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator MGRM (MGRM)
Monogram Technologies develops robotic systems for orthopedic surgery. This is a speculative R&D story in medical technology. A chart above 70 may reflect positive news about trials or approvals. Oversold territory (<30) is often associated with delays, setbacks, or general investor risk aversion.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-MGRM-MGRM&v=1772581137698 "RSI 14 indicator chart for the company's stock MGRM (MGRM)")
RSI 14 Market Segment - Medical instruments
Monogram Technologies aims to revolutionize orthopedics by combining surgical robotics with 3D-printed, custom-made implants. This chart tracks the collective sentiment in the medical device and robotics sector. It helps assess whether MGRM's momentum is part of the overall medtech hype or reflects technological risks.
RSI 14 for the overall market
Monogram (MGRM), a developer of surgical robots. This chart is its lifeline. In a euphoric mood, investors are ready to fund the "future of medicine," and hospitals are ready to buy expensive robots. In a panic, investors flee unprofitable R&D projects, and hospitals freeze capital expenditures, which is a double whammy.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast MGRM (MGRM)
Monogram Technologies is developing next-generation robotic systems (the MIRA robot) for orthopedic surgery, specifically joint implantation. This chart shows the average analyst forecast. Their targets are based on success in obtaining FDA approval and the company's ability to commercialize its robotic platform.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-MGRM-MGRM&v=1772581137795 "A chart showing analyst consensus forecasts for the expected stock price. MGRM (MGRM)")
The difference between the consensus estimate and the actual stock price MGRM (MGRM)
Monogram Technologies (MGRM) is a medical technology startup developing smart surgical robots and 3D-printed implants for joint replacement surgeries (knee, hip). This chart is a barometer of their R&D. It measures the gap between the price and the consensus target, reflecting the high, yet speculative, potential analysts see in their robotics.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-MGRM-MGRM&v=1772581137854 "A chart showing the difference between the consensus forecast and the actual stock price. MGRM (MGRM)")
Analyst consensus forecast for stock prices by market segment - Medical instruments
Monogram Technologies (MGRM) is a company developing a next-generation surgical robot for orthopedic surgeries (joint replacements) using 3D printing. This chart shows general expectations for the medical instrument sector. It reflects whether experts believe the surgical robotic assistance market will grow.
Analysts' consensus forecast for the overall market share price
Monogram Technologies (MGRM) is a company developing next-generation robotic systems for orthopedic surgery, specifically joint implants. This chart shows the overall "risk appetite." For Monogram, which is seeking to break into a market dominated by giants, overall market optimism (a rising chart) is critical to funding expensive developments.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index MGRM
Monogram Technologies (MGRM) is a robotic joint surgeon. They are developing a next-generation robotic system (with 3D-printed implants) that aims to make knee and hip replacement surgeries more precise and personalized. This graph is a clear indicator of faith in their R&D. It reflects their progress toward FDA approval and their chances of challenging the giants (Stryker, J&J).
AKIMA Market Segment Index - Medical instruments
Monogram Technologies develops next-generation robotic systems for orthopedic surgery, particularly joint replacements. This chart shows the average index for the medical instrument sector. It allows one to assess how promising Monogram's innovative approach to surgery is compared to the industry average.
The AKIM Index for the overall market
Monogram Technologies is a medtech company developing robotic systems and implants for orthopedic surgery. This chart, reflecting the market average, provides context. It helps assess how this speculative venture, seeking to enter a competitive market, stacks up against overall macroeconomic trends.
